- Treatment methods for lymes disease and associated debilitating conditions
-
A method is provided for treating human patients who have Lymes disease by using a psoralen compound, preferably administered in a dosage of 0.3 to 0.7 mg/kg, and activating same either in vitro or in vivo using electromagnetic radiation of a prescribed activating wavelength. The activation of the psoralen compound in the presence of a blood fraction from a patient suffering from Lymes disease produces a composition which will stimulate an effective immune response to the Lymes disease on the part of the patient.
- -
-
-
- DDQ Oxidation of 6- or 8-Allyl-7-hydroxycoumarins. A New Synthesis of Benzodipyrandiones and Furobenzopyranones
-
A novel synthesis of 2H,8H-benzodipyran-2,8-diones, 2H,8H-benzodipyran-2,8-diones, 2H-furobenzopyran-2-ones, and 7H-furobenzopyran-7-ones was achieved by developing 2-pyrone and furan ring over coumarin. 6- or 8-Allyl-7-hydroxycoumarins on oxidation with 2,3-dichloro-5,6-dicyanobenzoquinone (DDQ) afforded benzodipyrandiones and furobenzopyranones.The structures of the compounds now synthesized were established by analytical, spectral, and comparison with authentic samples prepared by the known procedures.
- Prashant, Avula,Krupadanam, Gazula Levi David,Srimannarayana, Gutely
-
p. 1191 - 1193
(2007/10/02)
-
- Treatment methods and vaccines for stimulating an immunological response against retroviruses
-
Human Immunodeficiency Virus infections, particularly AIDS, are treated by administering a psoralen compound which is subsequently activated by exposure to electromagnetic radiation (e.g. UVA light) whereby the activated psoralen compound attacks free virus and/or virus infected cells in the blood of the patient. The treated blood when presented to the patient's immune system engenders an effective immune response against the infection. The method has particular utility in the treatment of ARC patients who have depressed immune function.
- -
-
-
- Coumarin derivatives and method for synthesizing 5'-methyl psoralens therefrom
-
Two species of a coumarin derivative are disclosed, both of which may be produced from a 7-hydroxycoumarin precursor. The one species is an oxime and the other is a β-haloallyl ester. A method for making a psoralen compound in high yield comprises treating these coumarin derivatives with an acid to fuse a furan ring thereto, and recovering a 5'-methyl psoralen therefrom. The 5'-methyl psoralen may be produced in up to about 70% overall yield with respect to the 7-hydroxycoumarin precursor.
- -
-
-
- Photosensitizing benzofuranacrylics
-
The invention relates to 5-benzofuranacrylic acid compounds, preferably loweralkyl-substituted in the benzofuran ring system, which have photosensitizing activity, especially oral and topical activity, as well as low toxicity.
- -
-
-
- Process for making α-loweralkylfurocoumarins
-
α-Loweralkylfurocoumarins are produced by forming a β-haloalk-2-enyl, e.g., β-haloallyl, ether of a hydroxycoumarin having an active hydrogen in the position ortho to the hydroxy group, and heating the formed ether, preferably in dimethylaniline or like basic amine solvent. An abnormal Claisen rearrangement produces a novel o-hydroxy-(β-haloalk-2-enyl) coumarin intermediate which can be dehydrohalogenated directly without isolation to the desired α-loweralkylfurocoumarin, e.g., α-methylfurocoumarin.
- -
-
-